Cactus Acquisition Corp. 1 Ltd
Definitive agreement 2024-08-29- CIK 1865861
- CCTS
- IPO 2021-11-01
- $652K trust
- 175 filings
- IPO Size
- $127M
- raised at the IPO
- Trust
- $652K
- as of 2026-06-30
- Current Status
- Definitive Agreement
- from its latest filing
- IPO Year
- 2021
- year it listed
Filings, by quarter
175 filings over 23 quarters; violet bars carry a milestone
- 21 Q2: 1 filing
- 21 Q3: 3 filings
- 21 Q4: 23 filings
- 22 Q1: 6 filings
- 22 Q2: 1 filing
- 22 Q3: 1 filing
- 22 Q4: 4 filings
- 23 Q1: 10 filings
- 23 Q2: 13 filings
- 23 Q3: 4 filings
- 23 Q4: 10 filings
- 24 Q1: 19 filings
- 24 Q2: 25 filings
- 24 Q3: 14 filings
- 24 Q4: 18 filings
- 25 Q1: 2 filings
- 25 Q2: 3 filings
- 25 Q3: 4 filings
- 25 Q4: 5 filings
- 26 Q1: 2 filings
- 26 Q2: 1 filing
- 26 Q3: 5 filings
- 26 Q4: 1 filing
- S-1 filed 21 Q2
- IPO 21 Q4
- Definitive agreement 24 Q3
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
Cactus Acquisition Corp. 1 Limited is a blank-check company seeking a business combination with a technology-based healthcare business with a significant Israeli connection. The company is raising capital through an IPO and will hold proceeds in trust pending a business combination.
Investment Focus
Healthcare
Geographic Focus
Israel
Key Information
As the filings state it
- IPO Date
- 2021-11-01
- Total Redemptions
- $135M
- Jurisdiction of Incorporation
- Cayman Islands
- SIC
- 6770
- Merger Target
- Tembo e-LV B.V.
- SPAC Ticker
- CCTS
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The team includes life-sciences investors and healthcare executives with experience in Israeli healthcare and biotechnology, investment, company building, public-company management, and transaction execution. Its sponsor was formed by participants associated with CBI, Israel Biotech Fund, and Consensus Business Group/Kalistcare.